AMSbiopharma’s Post

Next month we publish the annual Pharmaceutical Innovation & Invention Indices. Follow us here to get the 2024 results when they launch. You can see the 2023 results here - https://lnkd.in/eKdXjzbv How do you think the 2024 results might differ? Any predictions to share? The question, 'if you give the same molecule to two companies in phase I, would they be equally successful?' remains a defining one. The answer is clearly 'no,' so the more interesting question is 'why'?'—perhaps one of the most important questions for our industry. When we first asked ourselves that question, more than a decade ago, it followed a more soul-searching one: ‘what if we're wrong?’ A healthy question, but not one that is typical of consultancies. Understanding how companies create value from their pipelines means being open to novel and multiple approaches - we produce this Index so that we know what we’re talking about when we talk about pharmaceutical innovation.

Thoughts on this? >> How genetic validation is transforming biotech industry in 2025 - Drug Discovery & Development >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #healthcare #pharma #competitivemarketing

Scaling up biologics production can be a complex and challenging journey, but it's a crucial step for bringing life-saving therapies to market. BioFocus delves into the essential strategies one should consider when preparing to scale up biologics manufacturing processes. This guide covers: • Streamlining bioprocess development • Optimizing production workflows • Ensuring quality and compliance • Leveraging innovative technologies Whether you're a biotech professional, a researcher, or just passionate about the future of medicine, this article is packed with valuable information to help you navigate the scaling-up process with confidence. Read the full article here: Essential Strategies for Scaling Up Biologics https://lnkd.in/eySccKfG #Biologics #Biotech #LifeSciences #Bioprocessing #Innovation #Healthcare #Pharmaceuticals #ScalingUp

The 2024 Pharmaceutical Innovation and Invention Index is live! We are proud to publish this year's indices: the 13th year of analysing innovation and invention in our industry. https://lnkd.in/e_b_TtCY The question, 'if you give the same molecule to two companies in phase I, would they be equally successful?' remains a defining one. The answer is clearly 'no,' so the more interesting question is 'why'?'—perhaps one of the most important questions for our industry. When we first asked ourselves that question, more than a decade ago, it followed a more soul-searching one: ‘what if we're wrong?’ A healthy question, but not one that is typical of consultancies. Understanding how companies create value from their pipelines means being open to novel and multiple approaches - we produce this Index so that we know what we’re talking about when we talk about pharmaceutical innovation. If you like, we’re ‘following the science’ rather than assuming we’re right.

There's something beautiful about seeing a small question we asked internally about 15 years ago steadily turn into one of the year's real events... The 2024 Pharmaceutical Innovation & Invention Index is here! The question we asked, that started this whole thing, was a simple one: if you gave the same molecule to two different companies in phase I, would they be equally successful? There's so much to think about in that small question... Innovation: Return on invention; creation of meaningful value from invention. Invention: Bringing ideas or technologies together in a novel way to create something that did not exist before. Congratulations to Novo Nordisk & Johnson & Johnson who top the Innovation & Invention Index respectively. See the full results here www.ideapharma.com/pii Notable results for the whole top 10 including: GSK Pfizer Eli Lilly and Company Bristol Myers Squibb AstraZeneca Roche Daiichi Sankyo US and Daiichi Sankyo Europe GmbH Merck Moderna Vertex Pharmaceuticals Regeneron hashtag #pharmaceutical hashtag #innovation hashtag #PIII2024

👉 Clinician wondering who the top innovators in drug development are? Definitely need to check out the PIII from the folks at IDEA Pharma | From R&D to RxD 🧠 Working in drug development exposed me to an entirely new industry that forms a critical part of the overall healthcare ecosystem 💊 Learning how medicines were made (and the challenges within the grueling and expensive development process) was incredibly synergistic with my patient care experience ⚡ I read this every year - you might like it too! ❓ Interested in all of the ways clinical experience could be valuable across the healthcare ecosystem for your career? Check out Next Degree - you might find the role just for you within our 2000+ jobs right now! PS - the folks at IDEA Pharma | From R&D to RxD are wicked smart

🤔 Is your operator and technician training program focused on improving your business? 👩💻 👨💻 DM me to find out how we can help you do this!

At Laurus Synthesis, we use advance analytics to shorten the learning curve, and get you results, faster. To learn how our refined capabilities can power your project, write to us at bdsynthesis@lauruslabs.com #Innovation #DrugDevelopment #DrugManufacturing #Biotech #Pharmaceutical #Innovation #CDMO #DataAnalytics #AdvancedAnalytics #Analytics  

In a recent interview with Pharmaceutical Commerce Magazine, Daniel Gagnon, VP of Global Strategy & Acquisition Integration, discusses the evolution of frozen and cold biologics in logistics. As demand for biologics and temperature-sensitive products soars, the industry is adopting advanced technologies and optimizing processes for safe and efficient global delivery. Handling biologics involves complex challenges, including temperature control, regulatory compliance, and supply chain management. UPS Healthcare has invested in state-of-the-art cold chain solutions with innovative packaging and real-time tracking systems that enhance visibility from end to end. ▶ Watch the interview: https://bit.ly/3AaeqbN 💡 Want to stay ahead in the evolving landscape of biologics, subscribe to our newsletter: https://bit.ly/3SCeM0V #UPS #Healthcare #Logisitics #ColdChain #Biologics

📰 How are biotech companies preparing to thrive in the rapidly evolving pharmaceutical landscape? As the biotech industry faces growing competition, regulatory hurdles, and funding pressures, companies are embracing adaptive strategies to secure growth in 2025 and beyond. By forming partnerships with larger pharmaceutical firms, biotech companies are streamlining R&D efforts and expanding their market reach. Data-driven approaches, including the use of AI and advanced analytics, are also being prioritized to accelerate drug discovery and reduce development costs. These innovations position biotechs for success while tackling the challenges ahead. Discover more about how biotechs are strategizing for the future 👉 https://lnkd.in/d84QSB_t #pharmaceuticals #biotechnology #researchanddevelopment #AI #drugdiscovery #pharmconnect